科達製造(600499.SH):邊程已通過大宗交易減持3770萬股
格隆匯 7 月 23日丨科達製造(600499.SH)公佈,公司於2020年7月23日收到公司股東樑桐燦、邊程的通知,自2020年7月21日至2020年7月23日期間,樑桐燦通過大宗交易方式合計增持公司股份2859萬股,佔公司總股本的1.51%;自2020年7月17日至2020年7月23日期間,邊程通過大宗交易方式合計減持公司股份3770萬股,佔公司總股本的2.00%。
此次權益變動後,信息披露義務人樑桐燦持有公司股份比例從18.36%增加至19.87%,邊程持有公司股份比例從9.21%減少至7.22%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.